CardioScale
@cardioscale.com
CardioScale’s Patented Cardiovascular Reserve Index - CVRI is a unique and advanced indicator that assesses patient’s hemodynamic state and trend to accurately projects its developing hemodynamic condition, without taking any invasive measures.
CardioScale's Company Logos
CardioScale's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#AB0000
Bright Red
171, 0, 0
0, 100, 34
0, 100, 100, 33
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#767574
Tapa
118, 117, 116
30, 1, 46
0, 1, 2, 54
About CardioScale
CardioScale is an Israeli medical device company that focuses on early detection of cardiovascular hemodynamic deterioration. Their patented Cardiovascular Reserve Index (CVRI) is a unique and advanced indicator that assesses a patient's hemodynamic state and trend without the need for invasive measures. This groundbreaking technology allows for the prediction of deterioration in patients, even when their vital signs appear normal.
By providing real-time patient status and trend information, CardioScale enables medical staff to make informed decisions regarding intervention, ultimately saving lives. The CVRI technology behind CardioScale is an integrated multi-vital sign index that provides a complete and objective picture of a patient's hemodynamic state. It is simple, non-invasive, and can be performed by anyone at any point of care.
CardioScale's CVRI has received a CE Mark approval and has been recognized for its exceptional performance, with 100% prediction of deterioration in a study conducted by the IDF's Medical Corps. CardioScale is revolutionizing patient care by revolutionizing patient care by predicting deterioration and enabling early intervention. With their innovative technology, they are saving lives and improving outcomes in various medical settings such as shock, sepsis, trauma, ICU, pre/post-operation, and chronic conditions
Company type
Partnership
Year founded
2012
Company size
2-10 employees
